Cargando…

A Retrospective Analysis of Isoniazid-Monoresistant Tuberculosis: Among Iranian Pulmonary Tuberculosis Patients

BACKGROUND AND OBJECTIVES: Isoniazid (INH) is one of the most potent anti-tuberculosis (TB) drugs. The spread and transmission of INH- resistant bacilli are likely to pose a significant problem for National TB control Program (NTP). In this study, we aimed to determine the trend of INH-monoresistant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varahram, Mohammad, Nasiri, Mohammad Javad, Farnia, Parissa, Mozafari, Mohadese, Velayati, Ali Akbar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942868/ https://www.ncbi.nlm.nih.gov/pubmed/24600483 http://dx.doi.org/10.2174/1874285801408010001

Ejemplares similares

Association of Mycobacterium Tuberculosis Lineages with IFN-γ and TNF-α Gene Polymorphisms among Pulmonary Tuberculosis Patient
por: Varahram, Mohammad, et al.
Publicado: (2014)

Molecular diversity of Mycobacterium tuberculosis strains indifferent provinces of Iran
por: Mozafari, Mohadese, et al.
Publicado: (2013)

Rapid Detection of Isoniazid Resistance in Mycobacterium tuberculosis by a Single Multiplex Allele-specific Polymerase Chain Reaction Assay
por: Taghavi, Kimia, et al.
Publicado: (2011)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014
por: Cornejo Garcia, Jose Gabriel, et al.
Publicado: (2018)

Nontuberculous Mycobacteria Isolation from Clinical and Environmental Samples in Iran: Twenty Years of Surveillance
por: Velayati, Ali Akbar, et al.
Publicado: (2015)

Delphi Survey on the Current and Future Korean Guidelines for Isoniazid-Monoresistant Tuberculosis
por: Seo, Wan, et al.
Publicado: (2023)

Prevalence and outcome of isoniazid-monoresistant tuberculosis at a university hospital in Saudi Arabia
por: Binkhamis, Khalifa M., et al.
Publicado: (2021)

The Recent-Transmission of Mycobacterium tuberculosis Strains among Iranian and Afghan Relapse Cases: a DNA-fingerprinting using RFLP and spoligotyping
por: Parissa-Farnia, et al.
Publicado: (2008)

Clinical Characteristics and Treatment Outcomes of Patients with Low- and High-Concentration Isoniazid-Monoresistant Tuberculosis
por: Wang, Tsai-Yu, et al.
Publicado: (2014)

Pattern of InhA and KatG mutations in isoniazid monoresistant Mycobacterium tuberculosis isolates
por: Charan, Ashok Singh, et al.
Publicado: (2020)

An Overview of Genetic Information of Latent Mycobacterium tuberculosis
por: Hamidieh, Faezeh, et al.
Publicado: (2021)

Molecular Epidemiology of Nontuberculous Mycobacteria Isolates from Clinical and Environmental Sources of a Metropolitan City
por: Akbar Velayati, Ali, et al.
Publicado: (2014)

Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains
por: Machado, Diana, et al.
Publicado: (2018)

Synchronous Comparison of Mycobacterium tuberculosis Epidemiology Strains by “MIRU-VNTR” and “MIRU-VNTR and Spoligotyping” Technique
por: Jafarian, Mehdi, et al.
Publicado: (2010)

Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis
por: Modlin, Samuel J., et al.
Publicado: (2021)

Colonization of Pneumocystis jirovecii in Chronic Obstructive Pulmonary Disease (COPD) patients and the rate of Pneumocystis pneumonia in Iranian non-HIV(+) immunocompromised patients
por: Sheikholeslami, Maryam Fatemeh, et al.
Publicado: (2013)

Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa
por: Salaam-Dreyer, Zubeida, et al.
Publicado: (2021)

Molecular identification of streptomycin monoresistant Mycobacterium tuberculosis related to multidrug-resistant W strain.
por: Bifani, P, et al.
Publicado: (2001)

Molecular Dynamic Simulations and Molecular Docking as a Potential Way for Designed New Inhibitor Drug without Resistance
por: Aghajani, Jafar, et al.
Publicado: (2022)

Co-infection of Mycobacterium tuberculosis and Pneumocystis jirovecii in the Iranian Patients With Human Immunodeficiency Virus
por: Sheikholeslami, Maryam Fatemeh, et al.
Publicado: (2015)

Treatment of isoniazid-resistant pulmonary tuberculosis
por: Kim, Yee Hyung, et al.
Publicado: (2008)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
por: Jhun, Byung Woo, et al.
Publicado: (2020)

Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism
por: Sistanizad, Mohammad, et al.
Publicado: (2011)

Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study
por: Cox, Helen, et al.
Publicado: (2021)

Effect of pulmonary hypertension on outcome of pulmonary tuberculosis
por: Marjani, Majid, et al.
Publicado: (2014)

Rapid Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis using TaqMan Allelic Discrimination
por: Darban-Sarokhalil, Davood, et al.
Publicado: (2016)

Influence of sex on the exposure to isoniazid in patients with pulmonary tuberculosis
por: Rivera, Juan Gonzalo Bardalez, et al.
Publicado: (2023)

Value of third sputum smear for detection of pulmonary tuberculosis in HIV infected patients
por: Marjani, Majid, et al.
Publicado: (2012)

Childhood Tuberculosis and Isoniazid Preventive Therapy Among Household Contacts of Sputum Positive Pulmonary Tuberculosis Patients: A Descriptive Observational Study
por: Shanbag, Namita, et al.
Publicado: (2022)

Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis
por: Sirous, Mehrandokht, et al.
Publicado: (2018)

Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda
por: Micheni, Lisa Nkatha, et al.
Publicado: (2021)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Utility of Gastric Lavage for Diagnosis of Tuberculosis in Patients who are Unable to Expectorate Sputum
por: Baghaei, Parvaneh, et al.
Publicado: (2011)

Prevalence of Non-Tuberculosis Mycobacterial Infections among Tuberculosis Suspects in Iran: Systematic Review and Meta-Analysis
por: Nasiri, Mohammad Javad, et al.
Publicado: (2015)

Assessment of Cystic Fibrosis Distribution Based on Air Pollution by Geographical Information System (GIS)
por: Hassanzad, Maryam, et al.
Publicado: (2022)

Evaluation of the relationship between smear positivity and high-resolution CT findings in children with pulmonary tuberculosis
por: Bolursaz, Mohammad Reza, et al.
Publicado: (2014)

Determination of isoniazid acetylation patterns in tuberculosis patients receiving DOT therapy under the Revised National tuberculosis Control Program (RNTCP) in India
por: Imam, Faisal, et al.
Publicado: (2020)

A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
por: van Beek, Stijn W., et al.
Publicado: (2021)

Isoniazid-Induced Psychosis in a Patient with Pulmonary Tuberculosis: A Case Report
por: Khanna, Shreshth, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kdol6kg2ds5lgbnib24plu3rfn